Clinical Characteristics of Importance to Outcome in Patients With Spondyloarthritis

NCT02948608 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2019-03-07

No results posted yet for this study

Summary

The objective of the study is to investigate extra-articular manifestations, pain mechanisms, patient-reported outcomes, comorbidities and association between these conditions in patients with spondyloarthropathy (SpA) treated with Biologics. Further, to assess the predictive value of baseline pain profile on treatment outcome after ≥ 3 months.

Conditions

  • Spondyloarthropathy

Sponsors & Collaborators

  • Odense University Hospital

    collaborator OTHER
  • Parker Research Institute

    collaborator OTHER
  • Spine Centre of Southern Denmark

    collaborator OTHER
  • Svendborg Hospital

    lead OTHER

Principal Investigators

  • Inger Marie J Hansen, MD, DmSci · Svendborg Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-01
Primary Completion
2019-03-31
Completion
2019-09-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02948608 on ClinicalTrials.gov